Moon Surgical
Private Company
Total funding raised: $36.9M
Overview
Moon Surgical is a private, commercial-stage medical device company pioneering accessible robotic assistance for surgery. Its flagship product, the Maestro System, is a compact, table-mounted robotic platform that integrates with a surgeon's preferred laparoscopic instruments, aiming to democratize robotic surgery by being more affordable and adaptable than large-scale robotic systems. The company has achieved FDA 510(k) clearance and CE Mark for Maestro, initiated U.S. and European commercial cases, and is actively developing AI-enhanced software capabilities through a partnership with NVIDIA. Backed by significant venture funding and led by a team with deep medtech experience, Moon Surgical is positioned to capture share in the high-growth surgical robotics market.
Technology Platform
Maestro Robotic Surgery System: A compact, table-mounted robotic platform with two arms that hold a surgeon's own laparoscopic instruments, combined with the Maestro Insights AI software suite powered by NVIDIA Holoscan for intraoperative data analytics and assistance.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Moon Surgical competes in the surgical robotics market, dominated by Intuitive Surgical. It differentiates by offering a compact, instrument-agnostic, and potentially lower-cost system, targeting a different customer segment. It also faces competition from other new entrants aiming for 'accessible robotics' and from large medtech companies (e.g., J&J, Medtronic) developing their own robotic platforms.